Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation.

被引:54
|
作者
Alpdogan, Ö
Muriglan, SJ
Kappel, BJ
Doubrovina, E
Schmaltz, C
Schiro, R
Eng, JM
Greenberg, AS
Willis, LM
Rotolo, JA
O'Reilly, RJ
van den Brink, MRM
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA
关键词
D O I
10.1097/01.TP.0000070167.81584.A2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Prolonged immunodeficiency after allogeneic bone marrow transplantation (allo BMT) results in significant morbidity and mortality from infection. Previous studies in murine syngeneic BAIT models have demonstrated that posttransplantation insulin-like growth factor (IGF)-I administration could enhance immune reconstitution. Methods. To analyze the effects of IGF-I on immune reconstitution and graft-versus-host disease (GVHD) after allo BMT, we used murine models for MHC-matched and -mismatched allo BMT. Young (3-month-old) recipient mice received 4 mg/kg per day of human IGF-I from days 14 to 28 by continuous subcutaneous administration. Results. IGF-I administration resulted in increased thymic precursor populations (triple negative-2 and triple negative-3) as determined on day 28 but had no effect on overall thymic cellularity. In the periphery, the numbers of donor-derived splenic CD3(+) T cells were increased and these cells had an improved proliferative response to mitogen stimulation. IGF-I treatment also significantly increased the numbers of pro-, pre-, and mature B cells and myeloid cell populations in the spleens of allo BMT recipients on day 28. The administration of IGF-I in combination with interleukin 7 had a remarkable additive effect on B-cell, but not on T-cell, lymphopoiesis. Finally, we tested the effects of IGF-I administration on the development of GVHD in three different MHC-matched and -mismatched models and found no changes in GVHD morbidity and mortality. Conclusion. IGF-I administration can enhance lymphoid and myeloid reconstitution after allo BMT without aggravating GVHD.
引用
收藏
页码:1977 / 1983
页数:7
相关论文
共 50 条
  • [1] Insulin growth factor-I can enhance lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation in murine models.
    Alpdogan, O
    Schmaltz, C
    Muriglan, SJ
    Doubrovina, E
    Kappel, BJ
    Greenberg, AS
    Rotolo, JA
    O'Reilly, RJ
    van den Brink, MRM
    BLOOD, 2001, 98 (11) : 649A - 649A
  • [2] Bone marrow lymphoid reconstitution following allogeneic bone marrow transplantation.
    Hasserjian, RP
    Horncastle, DE
    Nasher, ST
    LABORATORY INVESTIGATION, 1999, 79 (01) : 138A - 138A
  • [3] Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation.
    Alpdogan, O
    Muriglan, SJ
    Eng, JM
    Tjoe, KH
    van den Brink, MRM
    BLOOD, 2003, 102 (11) : 939A - 939A
  • [4] Insulin-like growth factor-I and bone mineral density
    Collins, D
    Woods, A
    Herd, R
    Blake, G
    Fogelman, I
    Wheeler, M
    Swaminathan, R
    BONE, 1998, 23 (01) : 13 - 16
  • [5] INSULIN-LIKE GROWTH FACTOR-I IS AN AUTOCRINE GROWTH-FACTOR IN MYELOID DIFFERENTIATION
    ARKINS, S
    REBEIZ, N
    REESE, DL
    BIRAGYN, A
    KELLEY, KW
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A85 - A85
  • [6] Hematopoietic and stromal reconstitution after haploidentical allogeneic bone marrow transplantation.
    Tabilio, A
    Aversa, F
    Regazzi, E
    Falzetti, F
    Covalovo, S
    Garau, D
    Rizzoli, V
    Martelli, MF
    Stella, CC
    BLOOD, 1996, 88 (10) : 1042 - 1042
  • [7] Insulin-like growth factor-I and the liver
    Bonefeld, Karen
    Moller, Soren
    LIVER INTERNATIONAL, 2011, 31 (07) : 911 - 919
  • [8] INSULIN-LIKE GROWTH FACTOR-I AND THE KIDNEY
    OSHEA, M
    MILLER, SB
    HAMMERMAN, MR
    SEMINARS IN NEPHROLOGY, 1993, 13 (01) : 96 - 108
  • [9] INSULIN-LIKE GROWTH FACTOR-I STIMULATES BONE TURNOVER IN OSTEOPOROSIS
    JOHANSSON, AG
    LINDH, E
    LJUNGHALL, S
    LANCET, 1992, 339 (8809): : 1619 - 1619
  • [10] SECRETION OF INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS BY MURINE BONE-MARROW STROMAL CELLS
    ABBOUD, SL
    BETHEL, CR
    ARON, DC
    JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (02): : 470 - 475